Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin

BACKGROUND/AIM: We investigated the synergistic effect between vancomycin and β-lactams against vancomycin-susceptible (VSSA) and nonsusceptible MRSA isolates [heterogeneous vancomycin-intermediate S. aureus (hVISA) and VISA]. MATERIALS AND METHODS: A total of 29 MRSA, including 6 VISA, 14 hVISA, an...

Descripción completa

Detalles Bibliográficos
Autores principales: SRİSRATTAKARN, Arpasiri, CHAİYAPOKE, Chonthicha, BOONCHAROEN, Sirikarn, WONGTHONG, Sujintana, CHANAWONG, Aroonwadee, TİPPAYAWAT, Patcharaporn, TAVİCHAKORNTRAKOOL, Ratree, LULİTANOND, Aroonlug
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569772/
https://www.ncbi.nlm.nih.gov/pubmed/33705643
http://dx.doi.org/10.3906/sag-1910-166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569772/
https://www.ncbi.nlm.nih.gov/pubmed/33705643
http://dx.doi.org/10.3906/sag-1910-166

Ejemplares similares